PI3K-IN-1

CAS No. 1349796-36-6

PI3K-IN-1 ( SAR245409; Voxtalisib )

Catalog No. M11414 CAS No. 1349796-36-6

PI3K-IN-1 is a potent inhibitor of PI3K.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 39 In Stock
5MG 61 In Stock
10MG 105 In Stock
25MG 208 In Stock
50MG 295 In Stock
100MG 478 In Stock
500MG 1062 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PI3K-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    PI3K-IN-1 is a potent inhibitor of PI3K.
  • Description
    PI3K-IN-1 is a potent inhibitor of PI3K, extracted from patent WO2012103524 A2 and WO2013147649 A2.
  • Synonyms
    SAR245409; Voxtalisib
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    DNA-PK;PI3Kα;PI3Kβ;PI3Kγ;PI3Kδ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1349796-36-6
  • Formula Weight
    599.66
  • Molecular Formula
    C31H29N5O6S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 27.5 mg/mL
  • SMILES
    O=C(NC1=CC=C(S(=O)(NC2=NC3=CC=CC=C3N=C2NC4=CC(OC)=CC(OC)=C4)=O)C=C1)C5=CC=C(C)C(OC)=C5
  • Chemical Name
    N-(4-(N-(3-((3,5-dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Acalisib

    Acalisib (GS-9820, CAL-120) is a potent, isoform-selective PI3K p110δ with IC50 of 12.7 nM.

  • Idelalisib

    Idelalisib is a selective inhibitor of p110δ(IC50 : 2.5 nM; in cell-free assays); shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.

  • GDC-0326

    A potent, selective, orally available PI3Kα inhibitor with Ki of 0.2 nM; displays 133, 20 and 33-fold selectivity over PI3Kβ, PI3Kδ and PI3Kγ, respectively.